Purchase Order FA301617P0019
- Not listed
- The Defense Health Agency awarded a definitive firm fixed price contract valued at $450,000 to Grifols Diagnostic Solutions Inc. on November 29, 2023, for a lease and service agreement covering three nucleic acid testing analyzers, labor, tools, equipment, transportation, and parts. The contract is scheduled for completion by May 28, 2026, and will be performed in San Antonio, Texas. This award carries no small business set-aside designation, allowing Grifols to compete directly based on its...
- The U.S. Department of the Air Force Air Education and Training Command awarded a $180,000.00 firm-fixed-price purchase order to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit company, for the delivery of 3 Nucleic Acid Testing Procleix Panther Systems. The contract has a completion date of November 28, 2023. Grifols Diagnostic Solutions Inc. has received over $8 million in federal awards as a prime contractor, providing critical medical laboratory equipment and supplies to...
- This federal contract award is for a LAB TESTING SYSTEM valued at $101,404.80. The contract was awarded by the Defense Health Agency to Grifols Diagnostic Solutions Inc., a global healthcare company that provides plasma-derived medicines, transfusion medicine, reagents, equipment, and testing services. The contract is a firm-fixed price Purchase Order with a completion date of September 30, 2021. This award is not associated with a set-aside program. Grifols supplies critical medical...
- This federal contract was awarded to Grifols Diagnostic Solutions Inc., a global healthcare company that provides plasma-derived medicines, transfusion medicine, reagents, equipment, and testing services. The $101,404.80 firm-fixed price purchase order was issued by the Defense Health Agency for a lab testing system, with a completion date of March 30, 2021. Grifols has received over $8 million in federal contracts as a prime contractor, supplying laboratory equipment, reagents, and test kits to...
- This federal contract was awarded to Grifols Diagnostic Solutions Inc., a global healthcare company that provides plasma-derived medicines, transfusion medicine, reagents, equipment, and testing services. The $821,122.93 firm-fixed price purchase order was issued by the Department of the Navy Bureau of Medicine and Surgery for the procurement of NUCLEIC ACID TESTING REAGENTS, with a completion date of January 17, 2019. Grifols is a frequent recipient of federal contracts to supply critical...
- This is a firm-fixed price purchase order contract awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Grifols Diagnostic Solutions Inc., a for-profit global healthcare company. The contract is for the delivery of 3 ULTRIO 1K kits and 1 WNV 5K kit, along with additional reagents and consumables, with a ceiling value of $149,460.78. The contract has a performance period ending on May 4, 2019 and was originally awarded on October 11, 2016. No set-aside...
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 8 (VISN 8) of the Department of Veterans Affairs to Grifols Diagnostic Solutions Inc., a global healthcare company that provides plasma-derived medicines, transfusion medicine, reagents, equipment, and testing services to the federal government. The contract, valued at $29,700.00, is for the delivery of ELISA infectious disease tests and has an ultimate completion date of June 28, 2024....
- The U.S. Department of Veterans Affairs (VA) awarded a firm-fixed-price delivery order to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit organization, to provide cost-per-test blood analyzers. The $180,856.87 contract has a completion date of July 29, 2021 and does not utilize a set-aside designation. Grifols Diagnostic Solutions is a division of the global healthcare company Grifols, which has received over $8 million in federal awards as a prime contractor for supplying critical...
- This federal contract award was issued by the Department of the Navy Bureau of Medicine and Surgery to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit organization, for the provision of serology testing reagents. The contract is a firm-fixed-price purchase order with a potential value of $202,809.60 and a completion date of September 30, 2020. The contract does not have a set-aside designation. Grifols Diagnostic Solutions is a global healthcare company that provides plasma-derived...
- This federal contract award to Grifols Diagnostic Solutions Inc., a division of the global healthcare company Grifols, is for the delivery of AUTOMATIC GEL TESTING equipment and services. The $58,471.14 firm-fixed-price contract was issued by the Department of Veterans Affairs (VA) under a GSA Schedule 66-III vehicle for Critical Analyzers and Laboratory equipment. Grifols will provide reagents, testing kits, blood analyzers, and associated equipment and services to support blood screening,...
This is a $595,000.00 firm-fixed-price purchase order awarded by the Air Education and Training Command, a defense agency, to Grifols Diagnostic Solutions Inc. for the lease of nucleic acid testing equipment. The contract does not have a set-aside designation. Grifols Diagnostic Solutions Inc. is a for-profit division of the global healthcare company Grifols that provides plasma-derived medicines, transfusion medicine, reagents, equipment, and testing services to various federal agencies. This award is likely part of Grifols' existing contract vehicles with the Department of Veterans Affairs, Department of Defense, and other federal customers for supplying critical medical laboratory equipment and supplies, including nucleic acid testing analyzers and associated reagents, to support blood screening, donor testing, and diagnostics for infectious diseases at military treatment facilities and VA medical centers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00008 | Supplemental Agreement for work within scope | $35.0k | 3/25/21 | |
| P00007 | Exercise an Option | $120.0k | 10/22/20 | |
| P00006 | Funding Only Action | $120.0k | 10/30/19 | |
| P00005 | Exercise an Option | $0 | 9/11/19 | |
| P00004 | Exercise an Option | $120.0k | 10/4/18 |